73 related articles for article (PubMed ID: 38428891)
1. Brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.
Uehara R; Obinata D; Hashimoto S; Nakahara K; Uchida H; Yoshizawa T; Mochida J; Yamaguchi K; Sakaguchi M; Ozawa Y; Mori F; Miura K; Ishige T; Masuda S; Nakayama T; Takahashi S
Medicine (Baltimore); 2024 Mar; 103(9):e37371. PubMed ID: 38428891
[TBL] [Abstract][Full Text] [Related]
2. A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutation.
Kosaka T; Hongo H; Aimono E; Matsumoto K; Hayashida T; Mikami S; Nishihara H; Oya M
Pathol Int; 2019 Dec; 69(12):715-720. PubMed ID: 31631483
[TBL] [Abstract][Full Text] [Related]
3. Foreign accent syndrome as a heralding manifestation of transformation to small cell neuroendocrine prostate cancer.
Broderick A; Labriola MK; Shore N; Armstrong AJ
BMJ Case Rep; 2023 Jan; 16(1):. PubMed ID: 36717160
[TBL] [Abstract][Full Text] [Related]
4. Small cell neuroendocrine prostate cancer with adenocarcinoma components-case report and literature review.
Artamonova N; Djanani A; Schmiederer A; Pipp I; Compérat E; di Santo G; Aigner F; von der Heidt A; Heidegger I
Transl Androl Urol; 2024 May; 13(5):868-878. PubMed ID: 38855597
[TBL] [Abstract][Full Text] [Related]
5. Systemic metastases in large cell neuroendocrine prostate cancer: a rare case report and literature review.
Xiao M; Tong W; Xiao X; Pu X; Yi F
Front Oncol; 2024; 14():1398673. PubMed ID: 38812779
[TBL] [Abstract][Full Text] [Related]
6. Severe hypercalcaemia in metastatic prostate cancer with biallelic BRCA2 mutations and lytic bone lesions.
Lazzari L; Ledet E; Hawkins M; Sartor O
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37562861
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of primary large cell neuroendocrine carcinoma of the prostate.
Nguyen N; Franz RD; Mohammed O; Huynh R; Son CK; Khan RN; Ahmed B
Front Oncol; 2024; 14():1341794. PubMed ID: 38515575
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic Syndromes in Neuroendocrine Prostate Cancer: A Systematic Review.
Abufaraj M; Ramadan R; Alkhatib A
Curr Oncol; 2024 Mar; 31(3):1618-1632. PubMed ID: 38534956
[TBL] [Abstract][Full Text] [Related]
9. Advanced prostate cancer with brain metastasis presenting with isolated severe headache without urinary symptoms.: Case report and literature review.
Nhungo CJ; Kitua DW; Nzowa B; Kasori M; Sensa V; Mkony C
Int J Surg Case Rep; 2024 Apr; 117():109458. PubMed ID: 38458020
[TBL] [Abstract][Full Text] [Related]
10. Treatment Outcomes of Second-Line Systemic Therapy for Neuroendocrine Prostate Cancer: A Report of Four Cases.
Tsubonuma Y; Funakoshi K; Takaba T; Jyojima K; Minato A; Tomisaki I; Harada K; Fujimoto N
J UOEH; 2024; 46(1):23-28. PubMed ID: 38479871
[TBL] [Abstract][Full Text] [Related]
11. Post-therapeutic squamous cell transformation of a metastatic prostate adenocarcinoma with comparison of molecular profiles: a case report and review of the literature.
Li P; Haines GK; Si Q; Baskovich B
Int J Clin Exp Pathol; 2024; 17(3):78-82. PubMed ID: 38577694
[TBL] [Abstract][Full Text] [Related]
12. Prominent response to platinum-based chemotherapy in a patient with
Daimon T; Kosaka T; Hongo H; Aimono E; Nakamura K; Mikami S; Nishihara H; Oya M
IJU Case Rep; 2021 Jul; 4(4):216-219. PubMed ID: 34258530
[TBL] [Abstract][Full Text] [Related]
13. The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review.
Matsubayashi H; Todaka A; Tsushima T; Kiyozumi Y; Harada R; Ishihara E; Higashigawa S; Ohike N; Sakamoto H; Sato J; Ishiwatari H; Sugiura T; Uesaka K
Fam Cancer; 2024 May; ():. PubMed ID: 38733420
[TBL] [Abstract][Full Text] [Related]
14. Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types.
Rao SR; Protheroe A; Cerundolo L; Maldonado-Perez D; Browning L; Lamb AD; Bryant RJ; Mills IG; Woodcock DJ; Hamdy FC; Tomlinson IPM; Verrill C
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628903
[TBL] [Abstract][Full Text] [Related]
15. Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinoma.
Matsugasumi T; Nakanishi H; Yokota T; Shiraishi T; Ukimura O
IJU Case Rep; 2020 Jul; 3(4):121-124. PubMed ID: 33392467
[TBL] [Abstract][Full Text] [Related]
16. Undifferentiated prostate cancer treated with docetaxel.
Kobayashi M; Yokoyama M; Inoue M; Fujii Y
IJU Case Rep; 2020 Jul; 3(4):125-127. PubMed ID: 33392469
[TBL] [Abstract][Full Text] [Related]
17. Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer.
Kurashina R; Kijima T; Okazaki A; Fuchizawa H; Suzuki I; Sakamoto K; Betsunoh H; Fukabori Y; Yashi M; Kamai T
IJU Case Rep; 2021 Mar; 4(2):69-73. PubMed ID: 33718807
[TBL] [Abstract][Full Text] [Related]
18. Rare metastasis in a patient with BRAF-mutated rectal cancer: choroidal metastasis - case report and literature review.
Demir H; Ekim MM; Özgül E; Davarci SE; Baykara M
GMS Ophthalmol Cases; 2024; 14():Doc03. PubMed ID: 38774401
[TBL] [Abstract][Full Text] [Related]
19. Novel case of androgen receptor-positive cancer of unknown primary without serum prostate-specific antigen elevation that became progression free in the long term after primary combined androgen blockade.
Matsuyama N; Naiki T; Naiki-Ito A; Chaya R; Kawai T; Etani T; Nagai T; Kato H; Kubota Y; Yasui T
IJU Case Rep; 2021 Jan; 4(1):59-63. PubMed ID: 33426501
[TBL] [Abstract][Full Text] [Related]
20. First successful case of platinum-based chemotherapy for neuroendocrine prostate cancer with
Omura M; Kosaka T; Aimono E; Nakamura K; Hongo H; Mikami S; Nishihara H; Oya M
IJU Case Rep; 2022 Jan; 5(1):41-44. PubMed ID: 35005470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
